HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer

NCT06709885 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Colon Adenocarcinoma

Interventions

DRUG: Chidamide + Tislelizumab + chemotherapy (CapeOX )
DRUG: CapeOX

Sponsor

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]